Metformin use in cancer survivors with diabetes reduces all-cause mortality, based on the Korean National Health Insurance Service between 2002 and 2015

Malignant neoplasms are the leading cause of death in Korea. We aimed to examine if metformin use in cancer survivors reduces all-cause mortality. This study was retrospectively designed based on data from the Korean National Health Insurance Service-National Health Screening Cohort (HEALS) between...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Medicine (Baltimore)
Päätekijät: Kim, Joungyoun, Bae, Yoon-Jong, Lee, Jae-woo, Kim, Ye-seul, Kim, Yonghwan, You, Hyo-Sun, Kim, Hyeong-Seop, Choi, Eun-A, Han, Ye-Eun, Kang, Hee-Taik
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lippincott Williams & Wilkins 2021
Aiheet:
5700
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7982185/
https://ncbi.nlm.nih.gov/pubmed/33725979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000025045
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia